| 1 |
Irwin Gerszberg |
AT&T |
682 |
| 2 |
Suresh B. Singh |
Vitae Pharmaceuticals |
69 |
| 3 |
Agis Kydonieus |
Agile Therapeutics |
52 |
| #4 |
Nathan Feldstein |
Surface Tech |
51 |
| #4 |
John H. Moorhouse |
Univation Technologies |
51 |
| #6 |
Lin Fei |
Colgate-Palmolive |
39 |
| #7 |
Nagaraj S. Dixit |
Colgate-Palmolive |
37 |
| #8 |
Suketu Sanghvi |
Par Pharmaceutical |
28 |
| #9 |
Albert I. Yezrielev |
ExxonMobil |
27 |
| #10 |
Francis Toscano |
Xpedite Systems |
25 |
| #11 |
Nirmal Mulye |
Nostrum Energy Pte. |
24 |
| #12 |
Stephen A. Martucci |
Accusoft |
21 |
| #12 |
Edward A. Tavss |
Colgate-Palmolive |
21 |
| #14 |
Benjamin A. Belinka, Jr. |
Cytogen |
20 |
| #14 |
Kedar N. Rustogi |
Colgate-Palmolive |
20 |
| #16 |
Franklin M. C. Chen |
— |
19 |
| #17 |
George L. Goeke |
Union Carbide |
16 |
| #18 |
Nachimuthu Soundararajan |
Bristol-Myers Squibb |
15 |
| #19 |
Mahmoud R. Rifi |
Union Carbide Chemicals & Plastics Technology |
13 |
| #19 |
Chitoor S. Subramaniam |
Creanova Ag |
13 |
| #21 |
John H. Bright |
American Cyanamid |
12 |
| #21 |
Maria Auxilia Dominique |
Bank of America |
12 |
| #23 |
Matthew Peter Szapucki |
Ashland Products |
11 |
| #23 |
Michael Galella |
Bristol-Myers Squibb |
11 |
| #23 |
Michael L. Low |
Abbott |
11 |
| #23 |
Sreenivas S. Bhat |
Bristol-Myers Squibb |
11 |
| #27 |
Alvin Goddard |
AT&T |
10 |
| #28 |
Michael C. Crossin |
Colgate-Palmolive |
9 |
| #28 |
Srinivas T. Rao |
Rca |
9 |
| #28 |
Y. Larry Zhang |
Fmc |
9 |
| #28 |
Mary Abraam Soliman |
L'Oreal |
9 |
| #28 |
Venkatesan Padyachi |
Gojo Industries |
9 |
| #28 |
Subramanyam Ayyalasomayajula |
Aetherpal |
9 |
| #28 |
Henry Leong |
Gte Products |
9 |
| #28 |
Zhili Li |
Insmed Incorporated |
9 |
| #36 |
Anu Mahashabde |
Ferring B.V. |
8 |
| #36 |
Arding Hsu |
Siemens Corporate Research |
8 |
| #36 |
Richard H. Ernst |
ExxonMobil |
8 |
| #36 |
Edwin R. Ernst |
ExxonMobil |
8 |
| #40 |
Vincent Lee |
Columbia University |
7 |
| #40 |
Sunil R. Bangad |
Bank of America |
7 |
| #40 |
Bao-Ding Cheng |
Colgate-Palmolive |
7 |
| #40 |
Jan-I Tu |
E.R. Squibb & Sons. |
7 |
| #40 |
Kuo-Yann Lai |
Colgate-Palmolive |
7 |
| #40 |
Frank C. Liu |
Rca |
7 |
| #40 |
Theodore F. Munday |
Fmc |
7 |
| #40 |
Adil Belihomji |
Cellco Partnership |
7 |
| #40 |
Lakmal Boteju |
Lexicon Pharmaceuticals |
7 |
| #40 |
Kothandaraman Shankaran |
Merck |
7 |
| #40 |
Rory Holmes |
Chicopee |
7 |